Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin C Taylor

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
Chemmedchem|June 28, 2023
Synthesis and Biological Activity of 2-Benzo[b]thienyl and 2-Bithienyl Amidino-Substituted Benzothiazole and Benzimidazole DerivativesLivio Racané, Katarina Zlatić, Maja Cindrić, et al.
European Journal of Medicinal Chemistry|September 14, 2020
Design, synthesis, antitrypanosomal activity, DNA/RNA binding and in vitro ADME profiling of novel imidazoline-substituted 2-arylbenzimidazolesAndrea Bistrović Popov, Luka Krstulović, Sanja Koštrun, et al.
Nature Communications|May 23, 2024
Enteric nervous system regeneration and functional cure of experimental digestive Chagas disease with trypanocidal chemotherapyArchie A Khan, Harry C Langston, Louis Walsh, et al.
Bioorganic & Medicinal Chemistry|September 4, 2016
Synthesis and biological evaluation of N-cyanoalkyl-, N-aminoalkyl-, and N-guanidinoalkyl-substituted 4-aminoquinoline derivatives as potent, selective, brain permeable antitrypanosomal agentsIrene Sola, Albert Artigas, Martin C Taylor, et al.
Plos Neglected Tropical Diseases|August 31, 2013
In vivo imaging of trypanosome-brain interactions and development of a rapid screening test for drugs against CNS stage trypanosomiasisElmarie Myburgh, Jonathan A Coles, Ryan Ritchie, et al.
Plos Neglected Tropical Diseases|May 31, 2024
A panel of phenotypically and genotypically diverse bioluminescent:fluorescent Trypanosoma cruzi strains as a resource for Chagas disease researchFrancisco Olmo, Shiromani Jayawardhana, Archie A Khan, et al.
Clinical and Experimental Immunology|March 16, 2025
FcγRIIB (CD32B) antibodies enhance immune responses through activating FcγRsAlexander P Simpson, Robert J Oldham, Kerry L Cox, et al.
RSC Medicinal Chemistry|December 8, 2025
Synthesis and evaluation of nitroheterocyclic aromatic adamantane amides with trypanocidal activity. Part IIAngeliki-Sofia Foscolos, Richard L Atherton, Maria Billia, et al.
Plos Neglected Tropical Diseases|April 18, 2020
Drug-cured experimental Trypanosoma cruzi infections confer long-lasting and cross-strain protectionGurdip Singh Mann, Amanda F Francisco, Shiromani Jayawardhana, et al.
Bioorganic & Medicinal Chemistry|February 14, 2015
Synthesis, biological profiling and mechanistic studies of 4-aminoquinoline-based heterodimeric compounds with dual trypanocidal-antiplasmodial activityIrene Sola, Sílvia Castellà, Elisabet Viayna, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Chemmedchem|June 28, 2023
Synthesis and Biological Activity of 2-Benzo[b]thienyl and 2-Bithienyl Amidino-Substituted Benzothiazole and Benzimidazole DerivativesLivio Racané, Katarina Zlatić, Maja Cindrić, et al.
European Journal of Medicinal Chemistry|September 14, 2020
Design, synthesis, antitrypanosomal activity, DNA/RNA binding and in vitro ADME profiling of novel imidazoline-substituted 2-arylbenzimidazolesAndrea Bistrović Popov, Luka Krstulović, Sanja Koštrun, et al.
Nature Communications|May 23, 2024
Enteric nervous system regeneration and functional cure of experimental digestive Chagas disease with trypanocidal chemotherapyArchie A Khan, Harry C Langston, Louis Walsh, et al.
Bioorganic & Medicinal Chemistry|September 4, 2016
Synthesis and biological evaluation of N-cyanoalkyl-, N-aminoalkyl-, and N-guanidinoalkyl-substituted 4-aminoquinoline derivatives as potent, selective, brain permeable antitrypanosomal agentsIrene Sola, Albert Artigas, Martin C Taylor, et al.
Plos Neglected Tropical Diseases|August 31, 2013
In vivo imaging of trypanosome-brain interactions and development of a rapid screening test for drugs against CNS stage trypanosomiasisElmarie Myburgh, Jonathan A Coles, Ryan Ritchie, et al.
Plos Neglected Tropical Diseases|May 31, 2024
A panel of phenotypically and genotypically diverse bioluminescent:fluorescent Trypanosoma cruzi strains as a resource for Chagas disease researchFrancisco Olmo, Shiromani Jayawardhana, Archie A Khan, et al.
Clinical and Experimental Immunology|March 16, 2025
FcγRIIB (CD32B) antibodies enhance immune responses through activating FcγRsAlexander P Simpson, Robert J Oldham, Kerry L Cox, et al.
RSC Medicinal Chemistry|December 8, 2025
Synthesis and evaluation of nitroheterocyclic aromatic adamantane amides with trypanocidal activity. Part IIAngeliki-Sofia Foscolos, Richard L Atherton, Maria Billia, et al.
Plos Neglected Tropical Diseases|April 18, 2020
Drug-cured experimental Trypanosoma cruzi infections confer long-lasting and cross-strain protectionGurdip Singh Mann, Amanda F Francisco, Shiromani Jayawardhana, et al.
Bioorganic & Medicinal Chemistry|February 14, 2015
Synthesis, biological profiling and mechanistic studies of 4-aminoquinoline-based heterodimeric compounds with dual trypanocidal-antiplasmodial activityIrene Sola, Sílvia Castellà, Elisabet Viayna, et al.
Pageof 10